Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Endogenous pigment" is not a single molecule or therapeutic target but rather a broad term referring to any colored substance produced naturally within living organisms that contributes to tissue coloration. These include several chemically distinct classes: 1. **Melanin**, derived from tyrosine via tyrosinase activity, provides color to skin, hair, eyes, certain brain regions, and is involved in protection against UV radiation. 2. **Hemosiderin**, formed from hemoglobin breakdown products during red blood cell turnover; accumulates especially with increased hemolysis. 3. **Bilirubin**, another hemoglobin-derived yellow-brown pigment associated with bile production and excretion. 4. **Lipofuscin**, an age-related "wear-and-tear" yellow-brown granular material composed mainly of lipid-protein complexes accumulating over time within post-mitotic cells. 5. **Porphyrins**, intermediates in heme biosynthesis that can accumulate abnormally due to metabolic defects. These substances are important both physiologically—for normal coloration—and pathologically—as markers of disease states when they accumulate abnormally[1][2][3][4][5]. The term "endogenous pigment" is too generic for use as a canonical drug target name because it encompasses multiple unrelated molecules rather than one defined protein/receptor/enzyme. In summary: “Endogenous pigment” refers generically to all natural body-produced pigments such as melanin, hemosiderin, bilirubin, lipofuscin etc., each with distinct structure/function/disease relevance but not itself a valid molecular drug target.[1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous pigment.